Metropolitan Life Insurance Company (MetLife)’s Ironwood Pharmaceuticals IRWD Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7,769	Closed	-$67.7K	–	1062
2024 Q1	$67.7K	Hold	7,769	–	–	﹤0.01%	1254
2023 Q4	$88.9K	Hold	7,769	–	–	﹤0.01%	1152
2023 Q3	$74.8K	Buy	7,769 +372	+5%	+$3.65K	﹤0.01%	1173
2023 Q2	$78.7K	Hold	7,397	–	–	﹤0.01%	1152
2023 Q1	$77.8K	Sell	7,397 -871	-11%	-$9.76K	﹤0.01%	1140
2022 Q4	$102K	Hold	8,268	–	–	﹤0.01%	1041
2022 Q3	$85.7K	Hold	8,268	–	–	﹤0.01%	1108
2022 Q2	$95.3K	Sell	8,268 -1,073	-11%	-$12.6K	﹤0.01%	1080
2022 Q1	$118K	Sell	9,341 -25,175	-73%	-$289K	﹤0.01%	1097
2021 Q4	$402K	Sell	34,516 -3,872	-10%	-$47.5K	0.01%	1567
2021 Q3	$501K	Sell	38,388 -6,629	-15%	-$85.7K	0.01%	1462
2021 Q2	$579K	Buy	45,017 +2,115	+5%	+$24.2K	0.01%	1425
2021 Q1	$480K	Buy	42,902 +1,535	+4%	+$16.2K	0.01%	1446
2020 Q4	$471K	Sell	41,367 -2,404	-5%	-$26.3K	0.01%	1393
2020 Q3	$394K	Sell	43,771 -5,378	-11%	-$53.5K	0.01%	1374
2020 Q2	$507K	Sell	49,149 -938	-2%	-$9.6K	0.01%	1188
2020 Q1	$505K	Buy	50,087 +784	+2%	+$9.21K	0.01%	1041
2019 Q4	$656K	Sell	49,303 -1,560	-3%	-$17.2K	0.01%	1166
2019 Q3	$437K	Buy	50,863 +6,092	+14%	+$59.2K	0.01%	1384
2019 Q2	$490K	Sell	44,771 -8,686	-16%	-$97.3K	0.01%	1316
2019 Q1	$606K	Hold	53,457	–	–	0.01%	1169
2018 Q4	$464K	Hold	53,457	–	–	0.01%	1239
2018 Q3	$826K	Hold	53,457	–	–	0.01%	1041
2018 Q2	$856K	Buy	53,457 +1,111	+2%	+$16.4K	0.01%	998
2018 Q1	$676K	Buy	52,346 +2,049	+4%	+$25.5K	0.01%	1088
2017 Q4	$631K	Sell	50,297 -58,694	-54%	-$767K	0.01%	1124
2017 Q3	$1.44M	Hold	108,991	–	–	0.01%	1061
2017 Q2	$1.72M	Buy	108,991 +749	+0.7%	+$10.9K	0.01%	997
2017 Q1	$1.55M	Sell	108,242 -3,170	-3%	-$43.3K	0.01%	1051
2016 Q4	$1.43M	Hold	111,412	–	–	0.01%	1106
2016 Q3	$1.48M	Sell	111,412 -2,635	-2%	-$30.8K	0.01%	1073
2016 Q2	$1.25M	Buy	114,047 +7,962	+8%	+$77.8K	0.01%	1137
2016 Q1	$972K	Buy	106,085 +1,540	+1%	+$12.7K	0.01%	1193
2015 Q4	$1.01M	Buy	104,545 +2,298	+2%	+$22.2K	0.01%	1181
2015 Q3	$892K	Sell	102,247 -3,118	-3%	-$29.1K	0.01%	1255
2015 Q2	$1.06M	Sell	105,365 -4,823	-4%	-$56.1K	0.01%	1247
2015 Q1	$1.48M	Hold	110,188	–	–	0.01%	1007
2014 Q4	$1.41M	Hold	110,188	–	–	0.01%	1121
2014 Q3	$1.2M	Hold	110,188	–	–	0.01%	1177
2014 Q2	$1.42M	Buy	110,188 +7,619	+7%	+$82.8K	0.01%	1147
2014 Q1	$1.06M	Buy	102,569 +12,305	+14%	+$138K	0.01%	1304
2013 Q4	$878K	Hold	90,264	–	–	0.01%	1415
2013 Q3	$896K	Buy	90,264 +6,982	+8%	+$68.5K	0.01%	1341
2013 Q2	$694K	Buy	+83,282	New	+$1.01M	0.01%	1476

Other funds holding IRWD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s IRWD Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2024, closing a stake of 7,769 shares — an estimated $67.7K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in IRWD in Q2 2013 and held it in 44 quarters. The position peaked at $1.72M in Q2 2017. 226 funds tracked by Wall St. Rank hold IRWD as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Ironwood Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 7,769 Ironwood Pharmaceuticals shares in Q2 2024, an estimated $67.7K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 44 quarters.
Metropolitan Life Insurance Company (MetLife)'s Ironwood Pharmaceuticals position peaked at $1.72M in Q2 2017.
226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.